MarketLens
Sign Up

Neuronetics: A High-Stakes Turnaround Play with 143% Upside Potential

1 months ago
SHARE THIS ON:

Neuronetics: A High-Stakes Turnaround Play with 143% Upside Potential

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News2 days ago

NRx Pharmaceuticals: Promising Ketamine Opportunity In Psychiatry

NRx Pharmaceuticals' KETAFREE ketamine opportunity could become a commercial business if FDA approval leads to a successful launch, with the bull case hinging on future commercialization.
Stock News1 months ago

BrainsWay: Building A Capital-Light Interventional Psychiatry Ecosystem

BrainsWay's Q1-2026 revenue rose 35% YoY, with a 75% gross margin, after expanding its capital-light leasing model. FY-2026 revenue is expected at $66–68M, with adjusted EBITDA growth of 86–100%.
Stock News1 months ago

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics and second-largest shareholder Jorey Chernett announced a constructive alignment framework with the Board and management, potentially easing governance friction and supporting strategic ex...

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

Generac, Amazon strike $2.4 billion long-term generator supply deal

Stock News2 hours ago

A Broad-Based Earnings Growth Picture as Revisions Stay Positive

Stock News2 hours ago

Why Intel Stock Jumped Today

Stock News2 hours ago

LARRY KUDLOW: Prosperity is as American as apple pie

Stock News2 hours ago

Diamondback Energy Inc (FANG) Stock Down 8.0% -- Now Undervalued? GF Score: 61/100